Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 2/20 | 0.46 |
| ▸ | PARP1 | P09874 | 5/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | CASP3 | P42574 | 5/20 | 0.41 |
| ▸ | CASP7 | P55210 | 2/20 | 0.41 |
| ▸ | CASP2 | P42575 | 1/20 | 0.41 |
| ▸ | CASP6 | P55212 | 1/20 | 0.41 |
| ▸ | CASP8 | Q14790 | 1/20 | 0.41 |
| ▸ | GSK3A | P49840 | 1/20 | 0.38 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.38 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.38 |
| ▸ | PPOX | P50336 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | RGS12 | O14924 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4515814 | 0.88 | GSK3B (0.44) | GSK3BPARP1KDM4EALDH1A1GAA | |
| SCHEMBL10354541 | 0.85 | GSK3B (0.43) | GSK3BPARP1KDM4EALDH1A1GAA | |
| SCHEMBL5970012 | 0.84 | GSK3B (0.50) | GSK3BPARP1KDM4EALDH1A1GAA | |
| SCHEMBL10713059 | 0.84 | GSK3B (0.50) | GSK3BPARP1KDM4EALDH1A1GAA | |
| SCHEMBL2359305 | 0.84 | AURKA (0.34) | GSK3BPARP1KDM4EALDH1A1GAA | |
| SCHEMBL2408327 | 0.82 | KDM4E (0.49) | GSK3BPARP1KDM4EALDH1A1GAA | |
| SCHEMBL5312970 | 0.82 | GSK3B (0.41) | GSK3BPARP1KDM4EALDH1A1GAA | |
| SCHEMBL8969034 | 0.81 | PARP1 (0.42) | GSK3BPARP1KDM4EALDH1A1GAA | |
| SCHEMBL1014384 | 0.81 | GSK3B (0.46) | GSK3BPARP1KDM4EALDH1A1GAA | |
| SCHEMBL113006 | 0.81 | GSK3B (0.46) | GSK3BPARP1KDM4EALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110270133-A | A kind of integral post plate preparation method and application based on PE sieve plate conjugation chemistry group | 深圳市百迈生命科学有限公司 | 2019-09-24 | — | — | CN | claimed |
| CN-119528791-A | Method for recovering N-hydroxymethyl phthalimide from 4-AA key intermediate residues | 山东汇海医药化工有限公司 | 2025-02-28 | — | — | CN | disclosed |
| CN-110270133-A | A kind of integral post plate preparation method and application based on PE sieve plate conjugation chemistry group | 深圳市百迈生命科学有限公司 | 2019-09-24 | — | — | CN | disclosed |
| CN-110270133-A | A kind of integral post plate preparation method and application based on PE sieve plate conjugation chemistry group | 深圳市百迈生命科学有限公司 | 2019-09-24 | — | — | CN | disclosed |
| CN-110128843-A | Fluorescent dye and its preparation method and application | 深圳大学 | 2019-08-16 | — | — | CN | disclosed |
| CN-107108552-A | Heterocyclic kinase inhibitors | 百时美施贵宝公司 | 2017-08-29 | — | — | CN | disclosed |
| WO-2015108835-A1 | 3,3-DISUBSTITUTED-1-HYDROXYTRIAZ-1-ENE 2-OXIDES AND WOUND-HEALING COMPOSITIONS USING THEM | SARMONT LLC (US) | 2015-07-23 | — | — | WO | disclosed |
| US-20140371316-A1 | DERIVATIVES OF PHENOXYISOBUTYRIC ACID | FABRICANT JILL S (US) | 2014-12-18 | — | — | US | disclosed |
| US-8859781-B2 | No-releasing nonoate(nitrogen-bound)sulfonamide-linked-coxib anti-cancer agents | Euclises Pharmaceuticals, Inc. (US) | 2014-10-14 | — | — | US | disclosed |
| EP-2782902-A2 | DERIVATIVES OF PHENOXYISOBUTYRIC ACID | Fabricant, Jill, S. (US) | 2014-10-01 | — | — | EP | disclosed |
| EP-0492442-A1 | Photographic elements containing removable filter dye | EASTMAN KODAK COMPANY (US) | 1992-07-01 | — | — | EP | disclosed |
| US-5008288-A | Skeletal & heat muscle disorders | CEPTOR CORPORATION | 1991-04-16 | — | — | US | disclosed |
| US-4866040-A | DRUG COVALENTLY BONDED TO AMINOCARNITINE FOR DELIVERY TO SPECI FIC SITES | CEPTOR CORPORATION | 1989-09-12 | — | — | US | disclosed |
| US-4774265-A | Process for preparing magnetic polymer particles | SINTEF (NO) | 1988-09-27 | — | — | US | disclosed |
| EP-0226346-A1 | Bicyclic sulfonamide derivatives | SHIONOGI & CO., LTD. (JP) | 1987-06-24 | — | — | EP | disclosed |
| US-4654267-A | Magnetic polymer particles and process for the preparation thereof | SINTEF (NO) | 1987-03-31 | — | — | US | disclosed |
| EP-0106873-B1 | PROCESS FOR THE PRODUCTION OF MAGNETIC POLYMER PARTICLES | SINTEF (NO) | 1986-01-29 | — | — | EP | disclosed |
| WO-1984002031-A1 | MAGNETIC POLYMER PARTICLES AND PROCESS FOR THE PREPARATION THEREOF | SINTEF (NO) | 1984-05-24 | — | — | WO | disclosed |
| EP-0106873-A1 | PROCESS FOR THE PRODUCTION OF MAGNETIC POLYMER PARTICLES. | SINTEF (NO) | 1984-05-02 | — | — | EP | disclosed |
| WO-1983003920-A1 | MAGNETIC POLYMER PARTICLES AND PROCESS FOR THE PREPARATION THEREOF | SINTEF (NO) | 1983-11-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140371316-A1 | DERIVATIVES OF PHENOXYISOBUTYRIC ACID | AGER, BPGM, FOSB | GSK3B 201/4885PARP1 1215/4885KDM4E 244/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.